Numinus Wellness (NUMI.V) announced that Health Canada has cleared their MAPS-sponsored single-arm, open-label safety and feasibility study evaluating MDMA-assisted therapy for post-traumatic stress disorder (PTSD). The study is being…
Psychedelics
MindMed (MNMD.Q) and healthcare data consolidator Datavant, announced a partnership wherein MindMed will make use of Datavant’s tech to link their clinical trial data to external data from both…
COMPASS Pathways (CMPS.Q) signed an MOU with South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King’s College London. The…
Numinus Wellness (NUMI.V) announced they are going to acquire Neurology Centre of Toronto (NCT), pursuant to a purchase agreement from July 2, 2021. To acquire the centre, Numinus will…
Cybin (CYBN.NE) announced that they have entered into an exclusive research and development collaboration agreement with TMS NeuroHealth Centers, a wholly-owned subsidiary of Greenbrook TMS (GTMS.T). The agreement will…
Fear & Loathing There’s several debates raging about which specific psychedelics to get behind, investors are trying to guess which ones will provide the necessary breakthroughs within the medical…
Revive Therapeutics (RVV.C) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. RVV holds 13 patents (issued and…
Delic Corp (DELC.C) announced that their wholly-owned subsidiary, DELIC Labs, has entered into a partnership agreement with Agilent. Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise,…
“Suicide Opportunity” I can’t remember what company it was, maybe MindMed, but one of their early pitch decks had a page titled ‘Suicide Opportunity’. Yesterday I wrote an…
Delic Holdings (DELC.C) announced their recently acquired entity Complex Biotech Discovery Ventures (CBDV) has been rebranded as Delic Labs. Delic Labs is a federally authorized psilocybin and cannabis research…